Immunai: Dropprint Genomics acquisition, leadership hires
Biotech firm Immunai has acquired Dropprint Genomics, a single-cell genomics software company. Rachel Gate, Dropprint CEO and cofounder, said, “Together, we will work to unlock insights into the functions of the immune system in disease.”
Immunai also has named staff to its executive leadership team and scientific advisory board:
- Peter Smibert, vice president of functional
- Alexandria Cogdill, director of business development
- Adeeb Rahman, senior director of single-cell immunology
- Danny Wells, senior vice president of strategic research
- New scientific advisory board members include Michael Kalos, Jimmie Ye and Regina Barzilay
